AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2018
Dec 12, 2018
30786_dirs_2018-12-12_a33f3c52-8e56-412f-a916-4f1d6e2fde3f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-12-11
Reporting Person: TUMOLO ANNETTE (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-11 | Bio-Rad A Common Stock | S | 1176 | $254.00 | Disposed | 1504.3476 | Direct |
| 2018-12-11 | Bio-Rad A Common Stock | M | 1200 | $159.32 | Acquired | 2704.3476 | Direct |
| 2018-12-11 | Bio-Rad A Common Stock | S | 1200 | $255.00 | Disposed | 1504.3476 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-12-11 | Non-Qualified Stock Option (right to buy) | $159.32 | M | 1200 | Disposed | 2026-09-07 | Bio-Rad A Common Stock (1200) | Direct |
Footnotes
F1: The option vests in five equal annual installments beginning September 7, 2017
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13